PROACTINA SA CHEMICAL SOLUTIONS PRO ACTI...
Desconocido
GLIOMARK: Validation of blood brain barrier permeability as a glioma biomarker by means of the radiotracer 99m...
PROACTINA CHIMIKI TECHNOLOGIA ANONIMI ETAIRIA
participó en un
H2020:
H2020-SMEInst-2014-2015
Objective of GLIOMARK is to clinically validate the permeability of the blood brain barrier (BBB) as an in vivo biomarker for the diagnosis...
2015-07-29 - 2021-12-31 | Financiado
2015-07-29 - 2021-12-31 | Financiado
NANORESISTANCE: Management of Resistance to Tyrosine Kinase Inhibitors with Advanced Nanosystems
PROACTINA CHIMIKI TECHNOLOGIA ANONIMI ETAIRIA
participó en un
FP7:
NANORESISTANCE introduces for the first time (i) receptor -independent targeting of Epidermal Growth Factor Receptor-kinase activity, (ii) n...
Financiado
Financiado
* No se disponen de datos de la empresa actual.